Randomization, Masking, and Allocation Concealment is indispensable for any trial researcher who wants to use state of the art randomization methods, and also wants to be able to describe these methods correctly.
Far too often the subtle nuances that distinguish proper randomization from flawed randomization are completely ignored in trial reports that state only that randomization was used, with no additional information. Experience has shown that in many cases, the type of randomization that was used was flawed. It is only a matter of time before medical journals and regulatory agencies come to realize that we can no longer rely on (or publish) flawed trials, and that flawed randomization in and of itself disqualifies a trial from being robust or high quality, even if that trial is of high quality otherwise.
This book will help to clarify the role randomization plays in ensuring internal validity, and in drawing valid inferences from the data. The various chapters cover a variety of randomization methods, and are not limited to the most common (and most flawed) ones. Readers will come away with a profound understanding of what constitutes a valid randomization procedure, so that they can distinguish the valid from the flawed among not only existing methods but also methods yet to be developed.
Table of Contents
Introduction. Randomization and Bias in Historical Perspective. A Review of Randomization and Allocation Concealment. Sympathetic Bias in Clinical Trials. Second Order Selection Bias in Randomized Trials. Third Order Selection Bias in Randomized Trials. A Survey of Randomization Methods in Recent Trials. A Comparison of Randomization Procedures. A Note on Unrestricted Randomization. The Case for Using Minimization To Prevent Selection Bias. Reporting of Randomization (Alexandra Winter. Graphical Representations of Randomization. Selection Bias in Studies with Unequal Allocation. The Evolution of the MTI Procedures. Automating the Maximal Randomization Procedure.
Vance W. Berger received holds a doctoral degree in Statistics from Rutgers University. His professional career has included work in the pharmaceutical industry (Janssen Research Foundation, Theradex, and some consulting for Pfizer), work in two centers of the Food and Drug Administration (Drugs and Biologics), and review work for a number of statistical and medical journals. An active researcher, Dr. Berger wrote a book on the design and analysis of randomized clinical trials (focusing on randomization methods). He has also authored numerous book chapters and scientific articles appearing in the peer-reviewed literature, and has presented numerous invited lectures on this topic. Dr. Berger was the recipient of the 2006 Gertrude Cox Award, recognizing "a statistician making significant contributions to statistical practice" by the Washington Statistical Society.